在绝经后骨质疏松症中研究甘油三-葡萄糖指数
Busra Korpe1, Caner Kose1, Sumeyye Mermi1
1Obstetrics and Gynecology Hospital, Ankara Etlik City Hospital, Ankara, Turkey.
Climacteric : the journal of the International Menopause Society
|December 5, 2024
概括
甘油三糖 (TyG) 指数与绝经后的骨质疏松症有关. 较高的TyG指数水平表明女性骨质疏松症风险增加,建议其用于代谢健康评估.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 骨健康 骨健康 骨健康
背景情况:
- 绝经后的骨质疏松症是一个重大的健康问题.
- 甘油三糖 (TyG) 指数正在成为代谢功能障碍的标志物.
研究的目的:
- 评估TyG指数与绝经后骨质疏松症之间的关联.
- 调查关于骨质疏松风险的TyG指数水平的纵向变化.
主要方法:
- 对517名绝经后妇女进行了回顾性分析.
- 基于骨矿物质密度 (T-分数) 的分类.
- 统计分析包括后勤回归和ROC曲线.
主要成果:
- 骨质疏松症组的TyG指数和甘油三水平明显较高.
- 纵向分析表明,随着骨质疏松症的发展,TyG指数的增加.
- 泰格指数在预测骨质疏松症方面表现出准确性 (AUC 0.767-0.818).
结论:
- TyG指数是绝经后骨质疏松症的一个有价值的指标.
- 建议将TyG指数等代谢指标纳入骨质疏松症管理中.
- 对有针对性的干预措施的进一步研究是有必要的.
相关概念视频
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Blood Studies for Cardiovascular System III: Serum Lipid Profile
132
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
132
Oral Hypoglycemic Agents: Biguanides and Glitazones
172
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
172
Dipeptidyl Peptidase 4 Inhibitors
171
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
171
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
159
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
159


